Literature DB >> 2717518

Hollow fibers as an oral sustained-release delivery system.

M A Hussain1, R C DiLuccio, E Shefter.   

Abstract

Phenylpropanolamine (PPA) bound to ion-exchange resin was encapsulated in hollow fibers made of segmented polyurethane. This system was examined as an oral sustained-release delivery system. The fibers were spun by the phase inversion process and cut into different aspect ratios (length/diameter). The U.S.P. basket dissolution method was used to evaluate the in vitro drug release kinetics and the effect of the aspect ratio on the release. For in vivo evaluation, selected fibers were orally administered to dogs in gelatin capsules. The fiber delivery system provided a sustained-release profile of plasma PPA and a longer terminal half-life when compared to an oral immediate-release formulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717518     DOI: 10.1023/a:1015847618671

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs.

Authors:  Y Raghunathan; L Amsel; O Hinsvark; W Bryant
Journal:  J Pharm Sci       Date:  1981-04       Impact factor: 3.534

2.  Periodontal therapy by local delivery of tetracycline.

Authors:  J M Goodson; A Haffajee; S S Socransky
Journal:  J Clin Periodontol       Date:  1979-04       Impact factor: 8.728

3.  Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.

Authors:  M A Hussain; B J Aungst; G Lam; E Shefter
Journal:  Biopharm Drug Dispos       Date:  1987 Sep-Oct       Impact factor: 1.627

  3 in total
  3 in total

1.  Applicability of dielectric measurements to the adsorption of beta blockers onto a pharmaceutical grade ion-exchange resin.

Authors:  L Marchal-Heussler; N Colling; E Benoit; P Maincent; J Bessiere
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

Review 2.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

3.  Hollow fibers as an oral sustained-release delivery system using propranolol hydrochloride.

Authors:  M A Hussain; R C DiLuccio; E Shefter; A R Hurwitz
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.